This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UH Law Center Professors Look To Future Of 'Genetics Revolution' In Panel Discussion Oct. 29

Scientific advances affect a wide range of sectors and legal issues beyond medicine

HOUSTON, Oct. 28, 2013 /PRNewswire-USNewswire/ -- Three University of Houston Law Center authorities on the law of genetics will talk about their research, as well as the latest trends in biotechnology, intellectual property and genetics, in a panel discussion at the law school. The event will take place from 4-6 p.m., Oct. 29, in the Hendricks Heritage Room.   


The panel comprises Professors Sapna Kumar, Jessica Roberts, and Barbara Evans. Each has conducted research and written extensively on genetic-related legal issues. The professors invite students and practitioners to join in a lively discussion of how lawyers can get involved with the "genetics revolution."

"Scientific advances after the Human Genome Project are starting to have broad impacts, not just in medicine, but throughout many diverse sectors of the U.S. economy," Evans noted. "The University of Houston has one of the nation's deepest teams of professors at the very forefront of genetics-related policy issues."

Kumar added, "Scholars and courts are only beginning to consider how intellectual property can affect the individual rights of patients. My research looks at how patents can impact the substantive due process rights of individual patients, and how current standing doctrine can leave these people without any recourse."

Roberts, widely viewed as one of the nation's leading thinkers on the Genetic Information Nondiscrimination Act, explores how genetics affects a wide range of interests within and beyond healthcare, such as employment law, criminal law and discrimination.

"Genetics is a fascinating example of how we negotiate the legal protection of health-related information," Roberts said. "My current scholarship explores how our protection of genetic information can inform the protection of other kinds of information, as well as the current trends in genetic-information discrimination litigation."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.83 1.30%
FB $118.09 -0.40%
GOOG $694.52 -0.53%
TSLA $234.89 -2.90%
YHOO $36.01 -1.40%


Chart of I:DJI
DOW 17,733.99 -157.17 -0.88%
S&P 500 2,059.44 -21.99 -1.06%
NASDAQ 4,760.5310 -57.0630 -1.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs